最終更新日：2025/11/30
In the Phase III study, finerenone significantly improved outcomes in patients with chronic heart failure and reduced the rate of hospital readmissions.
正解を見る
In the Phase III study, finerenone significantly improved outcomes in patients with chronic heart failure and reduced the rate of hospital readmissions.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
